Status:
COMPLETED
Sparing in Neuromuscular Blockade in COVID 19 ICU
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Neuromuscular Blockade
Human Characteristics
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective case-controlled study of the effect of the use of a neuromuscular blockade (NMB) monitor on the consumption of NMB agents in patients under mechanical ventilation in the contex...
Eligibility Criteria
Inclusion
- PCR-proven SARS-CoV-2 infection
- Use of VM (mechanical ventilation)
- Use of NMB agents for at least 48 hours
Exclusion
- Pregnancy
- extracorporeal membrane oxygenation (ECMO)
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04459533
Start Date
June 1 2020
End Date
June 1 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Intensive Care Medicine, Hôpital de la Croix Rousse, Hospices Civils de Lyon
Lyon, France, 69004